‘‘(ii) followup care after newborns are 
screened. 
‘‘(2) TIMING OF REPORTS.—The Secretary shall 
submit— 
‘‘(A) an interim report that includes the 
information described in paragraph (1), not 
later than 30 months after the date on which 
the first grant funds are awarded under this 
section; and 
‘‘(i) a subsequent report that includes 
the information described in paragraph 
(1), not later than 60 months after the 
date on which the first grant funds are 
awarded under this section. 
‘‘(g) ELIGIBLE ENTITY.—In this section, the term 
‘eligible entity’ means— 
‘‘(1) a State or a political subdivision of a 
State; 
‘‘(2) a consortium of 2 or more States or polit-
ical subdivisions of States; 
‘‘(3) a territory; 
‘‘(4) an Indian tribe or a hospital or outpatient 
health care facility of the Indian Health Service; or 
‘‘(5) other entities with appropriate expertise in 
newborn screening, as determined by the Secretary. 
VerDate Aug 31 2005 
20:59 Oct 23, 2007
Jkt 069200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H3825.IH
H3825
hsrobinson on PROD1PC76 with BILLS
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section— 
‘‘(1) $10,000,000 for fiscal year 2008; and 
‘‘(2) such sums as may be necessary for each 
of fiscal years 2009 through 2012.’’. 
SEC. 10. CONTINGENCY PLANNING. 
Part A of title XI of the Public Health Service Act 
(42 U.S.C. 300b–1 et seq.), as amended by section 9, is 
further amended by adding at the end the following: 
‘‘SEC. 1116. NATIONAL CONTINGENCY PLAN FOR NEWBORN 
SCREENING. 
‘‘(a) IN GENERAL.—Not later than 180 days after 
the date of enactment of this section, the Secretary, acting 
through the Director of the Centers for Disease Control 
and Prevention and in consultation with the Administrator 
and State departments of health (or related agencies), 
shall develop a national contingency plan for newborn 
screening for use by a State, region, or consortia of States 
in the event of a public health emergency. 
‘‘(b) CONTENTS.—The contingency plan developed 
under subsection (a) shall include a plan for— 
‘‘(1) the collection and transport of specimens; 
‘‘(2) the shipment of specimens to State new-
born screening laboratories; 
‘‘(3) the processing of specimens; 
VerDate Aug 31 2005 
20:59 Oct 23, 2007
Jkt 069200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H3825.IH
H3825
hsrobinson on PROD1PC76 with BILLS
‘‘(4) the reporting of screening results to physi-
cians and families; 
‘‘(5) the diagnostic confirmation of positive 
screening results; 
‘‘(6) ensuring the availability of treatment and 
management resources; 
‘‘(7) educating families about newborn screen-
ing; and 
‘‘(8) carrying out other activities determined 
appropriate by the Secretary. 
‘‘SEC. 1117. HUNTER KELLY RESEARCH PROGRAM. 
‘‘(a) ADDITIONAL
NEWBORN
SCREENING
TESTS 
GRANTS.— 
‘‘(1) IN GENERAL.—The Secretary, in conjunc-
tion with the Director of the National Institutes of 
Health and taking into consideration the rec-
ommendations of the Advisory Committee, shall es-
tablish a research program (to be known as ‘Hunter 
Kelly Newborn Screening Research Program’) by ex-
panding, carrying out, and coordinating research 
in— 
‘‘(A) identifying, developing, and testing 
the most promising new screening technologies, 
in order to improve already existing screening 
tests, which may include tests for Krabbe Dis-
VerDate Aug 31 2005 
20:59 Oct 23, 2007
Jkt 069200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H3825.IH
H3825
hsrobinson on PROD1PC76 with BILLS
ease and Insulin Dependent Diabetes Mellitus, 
and Turner Syndrome, increase the specificity 
of newborn screening, and expand the number 
of conditions for which screening tests are 
available; 
‘‘(B) experimental treatments and disease 
management strategies for additional newborn 
conditions, and other genetic, metabolic, hor-
monal and/or functional conditions that can be 
detected through newborn screening for which 
treatment is not yet available; and 
‘‘(C) other activities that would improve 
newborn screening, as identified by the Direc-
tor. 
‘‘(2) ADDITIONAL NEWBORN CONDITION.—For 
purposes of this subsection, the term ‘additional 
newborn condition’ means any condition that is not 
one of the core conditions designated by the Advi-
sory Committee. 
‘‘(b) FUNDING.—In carrying out the research pro-
gram under this section, the Secretary and the Director 
shall ensure that entities receiving funding through the 
program will provide assurances, as practicable, that such 
entities will work in consultation with the appropriate 
State departments of health, and, as practicable, focus 
VerDate Aug 31 2005 
20:59 Oct 23, 2007
Jkt 069200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H3825.IH
H3825
hsrobinson on PROD1PC76 with BILLS
their research on screening technology not currently per-
formed in the States in which the entities are located, and 
the conditions on the uniform screening panel (or the 
standard test existing on the uniform screening panel). 
‘‘(c) MONITORING
AND RESULTS.—The Director 
shall— 
‘‘(1) monitor and report on the activities result-
ing from any funding distributed under this section; 
and 
‘‘(2) on an annual basis— 
‘‘(A) publish and disseminate the results of 
such monitoring on as wide a basis as is prac-
ticable, which may include incorporation of 
these results in other newborn screening reports 
and posting on the Internet Clearinghouse es-
tablished under section 1112; 
‘‘(B) submit to the relevant committees of 
Congress the results of such evaluation, which 
may include incorporation of such results in 
other newborn screening reports being sub-
mitted to Congress. 
‘‘(d) NONDUPLICATION.—In carrying out programs 
under this section, the Secretary shall minimize duplica-
tion and supplement, not supplant, existing efforts of the 
type carried out under this section. 
VerDate Aug 31 2005 
20:59 Oct 23, 2007
Jkt 069200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H3825.IH
H3825
hsrobinson on PROD1PC76 with BILLS